Background-Both statins and vitamin E, by reducing the rate of lipid peroxidation, may interfere with oxidative stress, but the impact of their combination is unknown. Methods and Results-We randomized 43 hypercholesterolemic patients (21 men, 22 women, age 63Ϯ11 years) to either simvastatin, to achieve Ͼ20% reduction of total cholesterol, or simvastatin plus 600 mg/d vitamin E for 2 months. Patients were then crossed over to the alternative treatment. Lipid parameters documented patients' compliance to simvastatin, whereas plasma levels of vitamin E documented compliance and absorption of vitamin E. We assessed urinary excretion of the isoprostane 8-iso-prostaglandin F 2␣ (8-iso-PGF 2␣ ) as an in vivo index of oxidative stress at baseline and after each month of therapy. 8-Iso-PGF 2␣ was significantly reduced by simvastatin, from 361Ϯ148 pg/mg creatinine (meanϮSD) at baseline to 239Ϯ124 pg/mg creatinine after 1 month.